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Introduction
Breast cancer continues to be one of the leading causes of cancer related death in women, and mortality is almost exclusively a result of tumor metastasis. Advanced metastatic cancers are mostly incurable and available therapies generally prolong life to a limited extent. It is increasingly appreciated that in addition to tumor cell-intrinsic survival and growth programs, the microenvironment is crucial in supporting metastases formation (Erez and Coussens, 2011; Obenauf and Massague, 2015; Quail and Joyce, 2013) . Nevertheless, while years of research have revealed the central role of the microenvironment in supporting tumor growth and response to therapy at the primary tumor site (Albini et al., 2018; Hanahan and Coussens, 2012; Quail and Joyce, 2013) , the role of the metastatic microenvironment and the molecular crosstalk between stromal cells, including fibroblasts and immune cells at the metastatic niche are poorly characterized.
Preparation of secondary sites to facilitate subsequent tumor cell colonization has been described for multiple cancers (Peinado et al., 2017) . Secreted factors and extracellular vesicles from tumor and stromal cells were reported to instigate a permissive pre-metastatic niche by influencing the recruitment and activation of immune cells (Coffelt et al., 2015; Deng et al., 2012; Peinado et al., 2011; Qian et al., 2011; Quail et al., 2017) , and by modifying the composition of the extracellular matrix (ECM) (Erler et al., 2009; Malanchi et al., 2012; Nielsen et al., 2016; Oskarsson et al., 2011; Oskarsson and Massague, 2012) . Each metastatic microenvironment exerts specific functions that support or oppose colonization by disseminated tumor cells (Nguyen et al., 2009; Peinado et al., 2017) . Therefore, understanding distinct organ-specific mechanisms that enable metastatic growth is of crucial importance.
Lungs are one of the most common sites of breast cancer metastasis. Various immune cell populations were shown to be functionally important in facilitating breast cancer pulmonary metastasis (Albrengues et al., 2018; Coffelt et al., 2015; DeNardo et al., 2009; Fridlender et al., 2015; Jablonska et al., 2017) . However, very little is known about the role of fibroblasts during the complex process of metastases formation. Cancer-associated fibroblasts (CAFs) are a heterogeneous population of fibroblastic cells found in the microenvironment of solid tumors. In some cancer types, including breast carcinomas, CAFs are the most prominent stromal cell type, and their abundance correlates with worse prognosis (Liu et al., 2016) . We previously demonstrated a novel role for CAFs in mediating tumor-promoting inflammation in mouse and human carcinomas Erez et al., 2010) . We further characterized the origin, heterogeneity and function of CAFs in breast cancer (Cohen et al., 2017; Raz et al., 2018; Sharon et al., 2015) . Importantly, we found profound changes in the expression of pro-inflammatory genes in fibroblasts isolated from metastases-bearing lungs (Raz et al., 2018) . However, comprehensive profiling of metastases-associated fibroblasts was not previously done. Based on the central role of CAFs in supporting tumor growth at the primary tumor site (Kalluri, 2016) , we hypothesized that transcriptional reprogramming of lung fibroblasts is an important factor in the formation of a hospitable metastatic niche that supports breast cancer metastasis.
In this study, we set out to characterize the dynamic co-evolution of fibroblasts during pulmonary metastasis. To achieve this goal, we utilized novel transgenic mice that enable visualization, tracking, and unbiased isolation of fibroblasts from spontaneous lung metastases. Here we demonstrate the profiling and analysis of the dynamic evolution of fibroblast transcriptome at distinct disease stages, including early and late metastatic disease.
Results

Fibroblasts are activated in the lung metastatic niche and acquire tumor promoting traits
We previously demonstrated that fibroblasts at the primary tumor microenvironment are reprogrammed to obtain a pro-inflammatory and tumor-promoting phenotype (Cohen et al., 2017; Erez et al., 2010; Sharon et al., 2015) . Moreover, we found that fibroblasts are also modified at the lung metastatic niche (Raz et al., 2018) . In this study, we set out to characterize the changes in lung fibroblasts that mediate the formation of a hospitable niche in breast cancer metastasis. Fibroblasts at the primary tumor site were previously demonstrated to be reprogrammed by tumor cell-derived paracrine signaling (Jin et al., 2017; Sharon et al., 2015) . Therefore, we initially asked whether fibroblasts at the metastatic microenvironment are activated in response to tumor-secreted factors. We isolated primary lung fibroblasts from lungs of normal female mice (normal lung fibroblasts-NLF), incubated them with conditioned media (CM) from Met-1, a PyMT-derived breast carcinoma cell line (Borowsky et al., 2005) , and analyzed the effect of tumor-derived factors on multiple tasks associated with activation of fibroblasts. One of the central physiological roles of activated myofibroblasts is to facilitate wound healing, where their motility and contractility are crucial for wound closure (Rouabhia et al., 2013) . We therefore performed an in vitro wound closure assay. Quantification of the wound area indicated that fibroblasts incubated with tumor cell secreted factors had significantly enhanced motility and scratch closure ability as compared with control fibroblasts (Figure 1A, B ). Activated myofibroblasts are known to have enhanced matrix adhesions, leading to increased contraction of collagen gel matrices (Cooke et al., 2000) . Thus, we next analyzed the effect of tumor-secreted factors on the ability of lung fibroblasts to mediate collagen contraction. Fibroblasts were suspended in collagen matrices and incubated with Met-1 conditioned media or in serum-free conditions. We found that tumorsecreted factors significantly enhanced the capacity of NLF to contract collagen gels as compared with control non-activated fibroblasts ( Figure 1C , D). One of the prerequisites for metastatic progression is the ability of tumor cells to migrate to distant sites (Nguyen et al., 2009) . Therefore, we next examined whether reprogrammed lung fibroblasts can enhance tumor cell migration. To that end, we incubated tumor cells with secreted factors derived from activated lung fibroblasts (ALF CM) or with normal controls (NLF CM). Transwell migration assays indicated that tumor cells incubated with ALF-derived factors exhibited increased migratory capacity as compared with controls ( Figure 1E , F). Thus, normal lung fibroblasts are reprogrammed by signaling from breast cancer cells, resulting in acquisition of tumorpromoting properties. We next set out to analyze the activation of metastases-associated fibroblasts in vivo. To that end, we utilized MMTV-PyMT mice, a transgenic mouse model of mammary carcinogenesis and spontaneous lung metastasis (Lin et al., 2003) . We initially assessed the expression of αSMA, a known marker of activated fibroblasts (Kalluri and Zeisberg, 2006) , in normal lungs and in metastases-bearing lungs. We found that the abundance of αSMA expressing fibroblasts was significantly increased in metastatic lungs as compared with normal lungs ( Figure 1G , H). In order to be able to track fibroblasts in an unbiased manner, we employed a transgenic mouse model of genetically labeled fibroblasts (Raz et al., 2018) . Flow cytometric analysis of normal lungs as compared with lungs of tumor-bearing mice revealed significantly increased numbers of fibroblasts in the metastatic lung ( Figure 1I ), indicating that activation of fibroblasts at the metastatic niche includes changes in their abundance, as well as in their activation state. Taken together, these results demonstrate that breast cancer lung metastasis is associated with fibroblast activation in the lung metastatic microenvironment. 
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Figure 1. Fibroblasts are activated in the lung metastatic niche and acquire tumor promoting traits. (A)
Representative images of scratch closure assay at 0 hours and 24 hours following scratch. Lung fibroblasts were incubated with SFM (NLF-normal lung fibroblasts), or with Met-1 CM (ALF-activated lung fibroblasts), scale bar: 300µM. (B) Quantification of scratch closure shown in (A), ****p<0.0001, Two-way ANOVA multiple comparisons, Data are represented as mean ± SD, n=3. (C) Representative images of collagen contraction assay at 24 hours. Lung fibroblasts were embedded in collagen gel and incubated with SFM (NLF) or in Met-1 CM (ALF). (D) Quantification of collagen contraction shown in (C), *p<0.05, Data are represented as mean ± SD, n=8. (E) Representative images of transwell migration assay of Met-1 tumor cells incubated with NLF CM or ALF CM. scale bar: 100µM. (F) Quantification of (E). Migrated tumor cells were counted using ImageJ in multiple fields of view (FOV). **p<0.01, Data are represented as mean ± SD, n=3. (G) Representative images of aSMA staining in normal lungs isolated from FVB/n mice, (n=3), and metastases-bearing lungs isolated from MMTV-PyMT mice (n=3). Scale bar: 100µM (H) Quantification of aSMA mean fluorescent intensity (MFI) in multiple fields of view (FOV) from 3 slides per mouse. ***p<0.001. Data are represented as mean ± SD (I) Number of fibroblasts (CD45-CD31-EpCAM-YFP+) in total lungs from FVB/n;Col1a1-YFP mice (n=7) and PyMT; Col1a1-YFP mice (n=6) were counted using flow cytometric analysis. *p<0.05. Data are represented as mean ± SD.
Transcriptome profiling of metastases-associated fibroblasts reveals dynamic stagespecific changes in gene expression.
To analyze the dynamic co-evolution of fibroblasts at the lung metastatic niche we performed unbiased transcriptome profiling by RNA-seq of fibroblasts isolated from lungs at distinct metastatic stages. To enable visualization, tracking, and isolation of fibroblasts, we established transgenic mouse models of breast cancer with fibroblast-specific reporter genes: transgenic mice that express the fluorescent reporter YFP under the Collagen-1α promoter (Col1a1-YFP) were crossed with MMTV-PyMT mice to create PyMT;Col1a1-YFP transgenic mice, in which all fibroblasts are fluorescently labeled (Raz et al., 2018) . To explore the temporal dynamic changes in functional gene networks, we profiled fibroblasts (EpCAM -CD45 -YFP + cells) isolated from normal lungs, and from lungs with micro-or macrometastases (Figure 2A, B ). Micrometastases were defined as the latest time point in which metastases are not detectable macroscopically, or by CT imaging.
Initial data analysis indicated that fibroblasts isolated from lungs with macrometastases (macrometastases-associated fibroblasts-MAF) were strikingly different from NLF as well as from fibroblasts isolated from lungs with micrometastases (micrometastases-associated fibroblasts-MIF) ( Figure 2C , Figure S1 ). Notably, since fibroblasts were isolated from entire lungs, rather than from specific metastatic niches, the MIF fraction contained also normal, non-metastases-associated fibroblasts. As a result, initial data analysis did not reveal significant differences between NLF and MIF ( Figure 2C , Figure S1 ). To focus on the genes that are differentially expressed between the different stages, we selected the top 2% most upregulated and downregulated genes in each comparison (NLF vs. MIF, NLF vs. MAF, MIF vs. MAF), yielding a total of 871 genes. Notably, Venn Diagram analysis showed that only a small number of these genes were shared across the different stages, suggesting that each stage is defined by its own specific gene signature ( Figure 2D ). Unsupervised methods including Principal Component Analysis (PCA) and hierarchical clustering validated that each metastatic stage clustered separately and was defined by a unique gene signature ( Figure  2E , F). Thus, although the transcriptional changes in the fibroblasts isolated from micrometastases may have been masked by the presence of NLF in this fraction, analyses confirmed that MIF represent a bona fide functionally distinct stage.
Aiming to delineate the stage-specific gene signatures and the molecular mechanisms operative in metastases-associated fibroblasts, and to identify the most relevant functional pathways, we performed protein-protein interaction (PPI) analysis using the STRING platform (Szklarczyk et al., 2017) . We found that the 871 unique altered genes had significantly more interactions than expected (p-value<1*10 -16 ). Specifically, out of 871 genes, 491 genes were inter-connected with other genes from the list ( Figure 2G , Figure  S2A ). Furthermore, unsupervised hierarchical clustering and PCA analyses on the connected 491 genes indicated that their expression pattern maintained the distinct segmentation of the three fibroblast populations: NLF, MIF and MAF ( Figure 2H , I). Interestingly, the remaining unconnected genes did not maintain the segmentation of distinct stages ( Figure S2B ), suggesting that the stage-specific gene expression signatures represent PPI connected pathways that are functional in metastases-associated fibroblasts. Therefore, we designated these 491 genes "stage-specific gene signature" and further focused our subsequent analyses on their functional roles. Figure  S2B .
F E
Fibroblast metastases-promoting tasks are driven by functional gene signatures related to stress response, inflammation, and ECM remodeling.
We next asked whether the stage-specific gene signature in fibroblasts represents specific metastases-promoting tasks. To address this question, we performed further analysis of the selected genes in each stage by using the over-representation enrichment analysis of the Consensus Path DB (CPDB) platform (Kamburov et al., 2011) . Our focus in these analyses was based on three different databases: GO (Ashburner et al., 2000;  The Gene Ontology, 2019), KEGG (Kanehisa et al., 2017; Kanehisa and Goto, 2000) , and Reactome (Fabregat et al., 2018) . For our analysis, we selected terms that represent biological processes enriched in at least two databases, with a relative overlap of at least 0.2 and at least 2 shared entities ( Figure 3A ). Data analysis revealed significant and stage-specific changes in functional pathways including cellular stress response, extracellular matrix (ECM) remodeling and inflammation ( Figure 3B , Table S1 ).
Interestingly, we found that gene expression signatures in fibroblasts isolated from the micrometastatic stage were highly and specifically enriched for functions related to cellular response to stress, including HSF1 activation, heat shock response and response to unfolded protein (Table S1 ). Upregulated genes in MIF that were related to stress and protein folding included several heat shock proteins: Hspa8, Hsp90aa1, Hspd1, Hspe1 and others ( Figure 3C ). ECM remodeling terms were enriched in both MIF and MAF ( Figure 3B ), indicating the central importance of ECM modifications in facilitating metastasis. Notably, while ECM remodeling was operative throughout the metastatic process, the specific genes related to ECM remodeling in the different metastatic stages were distinct ( Figure 3D ).
Gene expression signatures in fibroblasts isolated from macro-metastases were highly enriched for inflammation-related gene sets ( Figure 3B , Table S1 ). Notably, while there was a slight decrease in inflammatory related signaling in MIF, it is based on a small number of genes, as compared with the plethora of genes related to inflammation and chemokine and cytokine activities upregulated in MAF ( Figure 3E ). Taken together, these findings imply that metastases-associated fibroblasts assume distinct functional roles during the process of lung metastasis.
Encouraged by these findings, we next set out to obtain further insights on functional pathways that were modified in fibroblasts isolated from different metastatic stages. To that end, we performed Gene Set Enrichment Analysis (GSEA) of the whole dataset (Subramanian et al., 2005) . We focused our analysis on the H collection: Hallmark gene sets that summarize specific well-defined biological states or processes based on multiple datasets (Liberzon et al., 2015) . Similarly to the results obtained in our previous analyses, we found several functions related to inflammatory responses enriched in MAF ( Figure 3F , Table  S2 ). Interestingly, we found that Myc target genes were the most highly and significantly enriched in both metastatic stages ( Figure 3G , Table S2 ), suggesting that this transcription factor may play a central role in the functional molecular co-evolution of metastasesassociated fibroblasts. Taken together, these findings imply that the transcriptome of lung fibroblasts is rewired during metastatic progression, driving changes in the expression of distinct molecular pathways. Moreover, the transcriptional changes in ECM remodeling and stress response, which are potential metastases-promoting tasks, are evident at early stages of metastases formation, suggest that fibroblasts play an important role already at the onset of the metastatic process. Table  S1 . (C-E) Bubble graph heat map presenting genes in selected group annotations. Circle size denotes the number of terms that included the gene, color indicates the average Log-transformed q-value of these terms.
MAF vs. MIF
TNFa signaling via NF-kB IL6-JAK-STAT3
Only genes found in at least 2 different terms are presented. (C) "Stress response and protein folding" enriched genes. (D) "Extracellular Matrix remodeling" enriched genes. (E) "Inflammatory signaling" and/or "Cytokine and Chemokine activity" enriched genes, genes with an average q-value>0.01 were excluded. (F) Gene Set Enrichment Analysis (GSEA) results for hallmark datasets upregulated in MAF vs. NLF related to inflammatory signaling, FDR<0.05, NES>2. See also Table S2 .
Multiple gene network analyses identify Myc as a central transcription factor in the rewiring of metastases-associated fibroblasts.
To further characterize the regulatory nodes that govern the functional changes in fibroblasts, we hypothesized that these changes may be driven by the transcription factors that were identified by the CPDB and GSEA analyses ( Figure 3 ). Specifically, we identified five candidate transcription factors (TFs) that were enriched in at least one analysis and in at least one metastatic stage: Hif1a, Hsf1, Myc, Nfkb1 and Stat3.
To rank these TFs, we performed knowledge-based multiple analyses examining their centrality in the selected gene signatures. First, we examined in how many different comparisons each TF was enriched. We found that Hsf1 was only enriched in the micrometastatic stage vs. normal lungs, and Hif1a was enriched only in the macro-metastatic stage. Nfkb1 and Stat3 were enriched in the macro-metastatic stage, compared with both normal and micro-metastases. Notably, only Myc was enriched in all three comparisons ( Figure 4A , blue, Table S3 ). We next examined the protein-protein interactions (PPIs) of these TFs utilizing the STRING platform, and counted the number of direct connections of each TF with the stage-specific gene signature. Stat3 had the largest number of connections, closely followed by Myc ( Figure 4A , orange, Table S3 ). In addition to STRING, we examined PPIs using ANAT (Advanced Network Analysis Tool) (Yosef et al., 2011) . In this platform, the inference is based on setting all the candidate TFs as anchors and the selected genes as targets in a network of protein-protein interactions (PPI), and searching for a putative compact sub-network that connects them. We analyzed the results according to four parameters: the number of direct connections of each TF, the total number of connected genes (including non-directly connected genes), the characteristic path length, and network centralization. Analysis of the results revealed that Myc had the largest number of direct connections, as well as the largest number of total connections and is overall connected to the fibroblast stage-specific gene signature with the shortest path and with the highest centrality ( Figure 4A , yellow, Figure 4B , Fig S3 , Table S3 ). These results suggested that Myc plays a central role in mediating the transcriptional rewiring of fibroblasts in the lung metastatic niche.
We next examined the specific connection of each TF as a regulator in the metastasesassociated gene network. To that end, we utilized the RegNetwork tool (Liu et al., 2015) , a knowledge-based database of gene regulatory networks. We found that Myc had the greatest number of targets, followed by Stat3 and Nfkb1 ( Figure 4A , green, Table S3 ). Finally, we analyzed the correlation of the metastases-associated gene network with each candidate TF using the VarElect tool (Stelzer et al., 2016) . This tool enables prioritization of genes related to a specific query term by using a direct and indirect relatedness score. We analyzed the scores of the stage specific signature genes with each candidate TF, and the number of directly related genes. The TFs were ranked based on the number and average score for the directly related genes, and the average score of the indirectly related genes. In agreement with previous analyses, Myc had the highest number of connections and the highest average score for both directly and indirectly related genes ( Figure 4A , pink, Figure  4C , Table S3 ). To consolidate these comprehensive gene network analyses, we performed a comparative analysis on the TF bioinformatics measurements listed in Figure 4A . The results indicated that Myc achieved significantly higher scores than all other TFs ( Figure 4D ,E). These results implicate the centrality of Myc in the dynamic transcriptional changes that govern the function of metastases-associated fibroblasts in lung metastasis.
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Myc is a central regulator in metastases-associated fibroblasts and contributes to their acquisition of tumor-promoting traits
Myc (myelocytomatosis oncogene) is a transcription factor involved in many biological processes, including cell growth and proliferation, cell stemness, and metabolism. Myc is deregulated in many human cancers, and is known to play an important role in the pathogenesis of cancer, particularly in cancer cells (Dang, 2012; Poole and van Riggelen, 2017) .
To validate the ranking results, we analyzed by qRT-PCR the expression of Myc in fibroblasts isolated from normal lungs, or from lungs with micro-and macrometastases. Analysis of the results indicated that Myc is significantly upregulated in macrometastasesassociated fibroblasts ( Figure 5A ). In addition, we assessed the expression of central Myc targets that were found to be upregulated in metastases-associated fibroblasts, including Hspe1, Hsp90aa1, Odc1 and Fosl1 (Belinky et al., 2015; Chakravorty et al., 2017) . We found that these Myc targets were upregulated in fibroblasts isolated from lungs with metastases ( Figure 5B) . Interestingly, the qRT-PCR results validated our findings in the RNA-seq data, in which Hsp90aa1 was upregulated in MIF, whereas the other Myc targets were upregulated in MAF ( Figure 5B ). Importantly, fibroblasts highly upregulated the expression of Myc in response to tumor cell secreted factors ( Figure 5C , left bars). To elucidate the functional importance of Myc in mediating lung fibroblast reprogramming, we targeted its expression by a specific Myc targeting siRNA in primary lung fibroblasts. Abrogation of Myc expression by siMyc resulted in significant inhibition of Myc expression as compared with control fibroblasts. Moreover, Myc inhibition abrogated the upregulation of Myc in response to tumor cell secreted factors in activated fibroblasts ( Figure 5C , right bars). We next assessed whether inhibition of Myc affected the upregulation of selected Myc target genes in activated lung fibroblasts. Analysis of the results indicated that the expression of Myc is central to the upregulation of its known targets ( Figure 5D ). Finally, we examined the importance of Myc for functional activation of fibroblasts in response to tumor cell-secreted factors, by analyzing hallmark functions of activated lung fibroblasts, including enhanced migration and matrix contraction. To that end, we performed a wound healing assay and collagen contraction assay with tumor-activated lung fibroblasts that were transfected with siMyc or with siCtrl. We found that siMyc fibroblasts were less contractile and exhibited significantly attenuated migration capacity as compared with controls ( Figure 5E-H) . Taken together, our findings imply that Myc has a central role in enhancing fibroblast activation and in mediating their acquisition of metastasis-promoting functions. 
High expression of MYC and the metastases-associated fibroblast gene signature is associated with worse survival in human breast cancer
Encouraged by these findings, we next asked if the metastases-associated gene signature is operative in human breast cancer. Since there are no available transcriptomic datasets of lung metastases we analyzed patient data from breast tumors. We initially analyzed the expression of genes that we found to be upregulated in murine metastases-associated fibroblasts (upMAG-upregulated metastases-associated genes) in the stromal and epithelial compartments of human breast tumors, utilizing a publicly available dataset (Ma et al., 2009 ). This analysis revealed that while some of the genes are more expressed in the epithelial compartment (cancer cells, E), 40% of the genes were significantly more expressed in the stromal compartment (S) of human breast tumors ( Figure 6A ). Motivated by this result, we then performed survival analysis based on the genes that were significantly overexpressed in the stroma, and found that high expression of 21 of these genes was correlated with worse prognosis in breast cancer patients, including: SERPINE1, PLAUR, FGFR4 and BCAT1 ( Figure 6B , Table S4 ). Notably, these results implicate stromal gene expression in predicting patient survival, and suggest that the expression of genes identified in metastasesassociated fibroblasts contributes to worse prognosis in human breast cancer.
Since we showed that MYC is a central regulator of fibroblast rewiring during metastatic progression in mice, we next asked whether stromal expression of upMAG in human breast cancer is related to MYC. Interestingly, analysis of MYC expression in the stromal compartment of breast cancer patients revealed that MYC is upregulated in breast cancer stroma in correlation with disease progression, as reflected by pathological grade: expression of MYC was elevated in grade 3 disease, compared with stroma isolated from more differentiated tumors ( Figure 6C ). Moreover, to assess the centrality of MYC in the stromal compartment of breast tumors, we performed correlation analysis between the expression of MYC and the expression of the upMAG signature. We found that stromal expression of MYC was positively correlated with stromal expression of multiple genes that we found to be upregulated in fibroblasts ( Figure 6D ). Furthermore, the number of MYC positively correlated genes was significantly higher than the number of negatively correlated genes ( Figure 6E ). Notably, both STAT3 and NFKB1 had significantly less positive correlations as compared with MYC, further supporting our findings that MYC is a central regulator of stromal rewiring in breast cancer ( Figure 6F ). We next stratified patients based on the expression of MYC and the expression of each gene from the upMAG signature into 4 groups: high-high, high-low, low-high, low-low, respectively, and performed survival analysis. Strikingly, in 80 different genes, including the MYC downstream genes validated in murine fibroblasts in Figure 5 , patients with combined overexpression (high-high) had the worst survival, while patients with combined lower expression had the best survival ( Figure 6G -H, Table S4 ). Taken together, these results indicate that the activation of MYC transcriptional networks in the stroma of breast tumors plays a role in tumor progression and survival in human breast cancer. 
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Low-Low p-value = 9.1X10 -8 p-value = 7.0X10 -8 p-value = 6.9X10 -8 p-value = 6.4X10 -8 PANX1 CDH12 APLP1 CDK5R1 BCAT1 Figure 6 . High expression of MYC and the metastases-associated fibroblast gene signature is associated with worse survival in human breast cancer. (A) Heat Map presenting upregulated metastasesassociated genes (upMAG) that were significantly overexpressed in the stroma of human breast cancer (S) as compared with the epithelial (cancer cell) tissue (E), based on GSE14548, q-value<0. 05. (B) Kaplan-Meier analyses for overall survival in breast cancer patients in the METABRIC cohort based on the expression of genes found to be overexpressed in the stroma in (A). High=top 20%, Low=bottom 80%, p-value<0.05. See also Table S4 . (C) Box-plot of MYC expression in tumor associated-stroma (S) from the GSE14548 by disease grade (Stroma-grade 1: S1; Stroma-grade 2: S2; Stroma-grade 3: S3). One-way ANOVA with Tukey correction for multiple comparisons, *p-value<0.05. (D) Positive correlations between the expression of MYC and the expression of upMAG in tumor-associated stroma based on GSE14548. P-value<0.05. (E) Comparison between the number of significant positive and significant negative correlations between upMAG and MYC in tumor-associated stroma based on GSE14548. Chi-square test, ****p-value<0.0001 (F) Comparison between the number of significant positive correlations between upMAG and MYC, NFKB1 and STAT3 in tumor-associated stroma based on GSE14548. Chi-square test, ****p-value<0 .0001 (G-H Figure 5 .
Discussion
In this study we set out to elucidate the dynamic changes in the stromal compartment that facilitate the formation of a hospitable metastatic niche during breast cancer metastasis to lungs. We utilized a unique model of transgenic mice that enabled unbiased isolation of fibroblasts from spontaneous lung metastasis and performed comprehensive analysis of the transcriptome of fibroblasts isolated from normal lungs, and lungs with micro-or macrometastases. By employing multiple platforms of data analysis, we integrated ontology analyses with data on protein interactions and functional pathways from knowledge-based databases to identify the relevant and stage-specific gene signatures that imply functional tasks of metastases-associated fibroblasts.
Importantly, we performed the analysis on fibroblasts isolated directly from fresh tissues, with no additional culture step that may affect gene expression. Our findings indicated that ECM remodeling programs were instigated early in micrometastases, and persisted to be functional throughout the metastatic pathway, while other signaling pathways were activated in a stage-specific manner. Activation of the cellular stress response was associated with micrometastases, and inflammatory signaling was instigated in fibroblasts isolated from advanced metastases, suggesting that fibroblasts are transcriptionally dynamic and plastic, and that they adapt their function to the evolving microenvironment (Figure 7) .
Initial analysis of the RNA-seq data revealed distinct gene signatures associated with early and advanced metastatic disease. By performing step by step analysis, utilizing the STRING and CPDB platforms combined with GSEA, we unraveled multiple pathways operative in fibroblasts in different metastatic stages, relying not only on altered gene expression but also on mechanistic significance and interaction of genes.
Interestingly, this multi-layered analysis indicated that fibroblasts isolated from micrometastases instigated the expression of genes related to cellular response to stress, including the transcriptional regulator Hsf1. Hsf1 was previously shown to be upregulated in CAFs in early stage breast and lung cancers and to drive a stromal tumor-promoting transcriptional program that correlated with worse prognosis (Scherz-Shouval et al., 2014) . Moreover, Hsf1 was recently implicated in activating stromal expression of Dickkopf-3 (Dkk3) in mammary fibroblasts, which is a central modulator of their pro-tumorigenic activity, thus linking Hsf1 with reprogramming of stromal fibroblasts to CAFs (Ferrari et al., 2019) . Our findings expand these observations, and show that activation of Hsf1 transcriptional regulation in lung fibroblasts occurs during the early stages of metastasis and may play an important role in instigating tumor-promoting tasks in metastases-associated fibroblasts.
In addition to stress response, our findings indicated that ECM remodeling is a central task of metastases-associated fibroblasts throughout the metastatic cascade. Indeed, ECM components and remodeling were demonstrated to facilitate breast cancer metastasis to lungs, and pancreatic cancer metastasis to liver (Cox et al., 2013; Malanchi et al., 2012; Nielsen et al., 2016; Oskarsson et al., 2011; Yuzhalin et al., 2018) . We show that transcriptional rewiring of fibroblasts to mediate tasks such as collagen synthesis and ECM organization is a central function of metastases-associated fibroblasts, which is instigated early during the metastatic process and persists during advanced metastatic disease.
Notably, analyzing the central pathways in fibroblasts that were isolated from advanced metastases, indicated that metastases-associated fibroblasts upregulated pro-inflammatory pathways including multiple cytokines and chemokines. CAFs are known to play a central role in mediating tumor-promoting inflammation at the primary tumor site . Importantly, in recent years activation of inflammation has also emerged in shaping of the metastatic microenvironment (Albrengues et al., 2018; Coffelt et al., 2015; Quail et al., 2017) , but the role of fibroblasts in mediating inflammation at the metastatic site was not previously shown. Our findings implicate CAF-derived inflammatory signaling in promoting the growth of lung metastases. Further studies are required to determine which proinflammatory factors upregulated in metastases-associated fibroblasts are functionally important in formation of a hospitable metastatic niche in lungs.
We further characterized the molecular mechanisms operative in metastases-associated fibroblasts, by identifying the central transcription factors that drive the metastasesassociated gene programs upregulated in lung fibroblasts. Our analyses revealed several central regulators that are operative in metastases-associated fibroblasts, including the wellknown modulators of CAF activity Nfkb1 Erez et al., 2010) and Stat3 (Chakraborty et al., 2017; Li et al., 2018) . Surprisingly, the most prominent regulator in the metastasis-associated fibroblasts network was the transcription factor Myc. While the importance of Myc in promoting cell transformation and tumorigenesis is well established (Poole and van Riggelen, 2017) , its role in the tumor stroma is largely uncharacterized. Myc expression in tumor cells was shown to drive an inflammatory and immunosuppressive microenvironment (Kortlever et al., 2017) . Moreover, the expression of Myc in the stromal compartment was suggested to mediate metabolic and transcriptional reprogramming of fibroblasts (Minciacchi et al., 2017; Yan et al., 2018) . Our study identifies Myc as a central regulator in the transcriptional plasticity of metastases-associated fibroblasts. Indeed, inhibition of Myc attenuated tumor promoting functions of fibroblasts, confirming that Myc functionally contributes to their acquisition of tumor promoting traits. Importantly, validation of these findings in human breast cancer patients revealed that stromal expression of Myc and its downstream genes is highly correlated with worse survival in breast cancer patients. Stromal gene expression was previously found to be associated with bad prognosis in colon cancer (Calon et al., 2015) . Our findings implicate activation of Myc and stromal gene expression in breast cancer patient survival. Taken together, these findings indicate that in addition to its known role in driving carcinogenesis in tumor cells, Myc functions in stromal rewiring in the tumor microenvironment in both primary tumors and metastases of breast cancer.
In summary, we show that integration of multiple analytical platforms of gene expression, connectivity and function provided a powerful insight on functional and temporal regulation of the dynamic transcriptome of fibroblasts in lung metastasis. We uncovered central molecular pathways that drive the activation of growth-promoting tasks in fibroblasts via known regulators of CAF tumor-promoting activities including Stat3, Nfkb1, and Myc, a novel regulator of fibroblast metastases-promoting tasks. Our findings elucidate for the first time the dynamic transcriptional co-evolution of fibroblasts during the multi-stage process of breast cancer metastasis. The co-evolution of lung fibroblasts at the metastatic microenvironment is driven by stage-specific transcriptional plasticity that activates growth-promoting tasks including stress response, ECM remodeling and instigation of inflammatory signaling. OS, YR conceived and carried out experiments; NC and LM participated in experiments, OS analyzed data and generated the figures; OM, DS and HS analyzed data, RS provided essential resources; IT was involved in data analysis and discussions; NE designed and supervised the study; OS and NE wrote the manuscript.
Normal
Macro-metastases Micro-metastases
Declaration of Interests
The authors declare no conflict of interests.
Methods
Mice
All experiments were performed using 6-8 weeks old female mice, unless otherwise stated. All experiments involving animals were approved by the Tel Aviv University Institutional Animal Care and Use Committee. FVB/n Col1a1-YFP mice were a kind gift from Dr. Gustavo Leone. FVB/N-Tg (MMTV-PyMT) 634Mul/J were backcrossed with FVB/n;Col1a1-YFP mice to create PyMT;Col1a1-YFP double-transgenic mice as described previously (Raz et al., 2018) . All animals were maintained within the Tel Aviv University Specific Pathogen Free (SPF) facility.
Cell cultures
Met-1 mouse mammary gland carcinoma cells: Met-1 cells were a gift from Prof. Jeffrey Pollard. Met-1 cells were plated on 100mm plastic dishes and cultured with DMEM medium supplemented with 10% FCS, 1% penicillin-streptomycin and 1% Sodium-pyruvate (Biological Industries).
Primary lung fibroblasts cultures: Lungs were isolated from 6-8 weeks old FVB/n female mice. Single cell suspensions were prepared as previously described (Sharon et al., 2013) . Single cell suspensions were seeded on 6-well plates pre-coated with Rat tail collagen (Corning; 354236). Cells were grown in DMEM media supplemented with 10% FCS, and maintained at 37°C with 5% CO 2 .
Conditioned media
Tumor cell conditioned media (Met-1 CM): cells were cultured as described above. When cells reached 80% confluency, plates were washed twice with PBS and fresh serum free DMEM medium (SFM) was applied. After 48h, medium was collected, filtered through 0.45μm filters under aseptic conditions, flash-frozen in liquid nitrogen and stored at -80°C. DMEM SFM supplemented as above was used as control.
Normal lung fibroblasts (NLF) or Activated lung fibroblasts (ALFs) conditioned media: NLF were plated as described above. CM was prepared by incubating NLF with either SFM (for NLF CM) or Met-1 CM (for ALF CM) for 24 hours. After 24h, plates were washed twice with PBS and cells were incubated for additional 24h with fresh SFM. After 48h, medium was collected, filtered through 0.45μm filters under aseptic conditions, flash-frozen in liquid nitrogen and stored at -80°C.
Scratch assay
NLF were plated in a 96-well IncuCyte® imageLock plate (Essen BioSciense). SFM was applied for 16h. Wells were then washed three times with PBS and a scratch was made using the IncuCyte® WoundMaker (EssenBiosciense). Wells were washed three times with PBS and Met-1 CM or SFM were applied. The plate was placed in the IncuCyte® system (Essen BioSciense) for 48 hours. Images were analyzed using the IncuCyte® software.
Collagen contraction
NLF were plated as mentioned above and incubated with SFM for 16h. Following, Cells were detached from dishes with trypsin and counted. A total of 1.5×10 5 fibroblasts were suspended in a medium and collagen mixture [Met-1 CM or SFM mixed with High Concentration Rat Tail Collagen, type 1 (BD bioscience)], and allowed to set at 37°C for 45 min. Met-1 CM or SFM were applied, gels were released and incubated for 24 hours. Gels were photographed at various time points. ImageJ software was used to measure gel area and assess collagen contraction.
Migration assay
Met-1 (5×10 4 ) cells were placed into the upper chamber of 24 Transwell inserts, with pore sizes of 8µm, in 300µl NLF CM or ALF CM. Following 24h incubation, the upper side of the apical chamber was scraped gently with cotton swabs to remove non-migrating cells, fixed with methanol and stained with DAPI. Migrated cells were documented under a fluorescence microscope. ImageJ software was used to quantify migration.
Immunostaining
Lungs were harvested, shortly washed in PBS and embedded in Optimal Cutting Temperature compound (O.C.T, Tissue-Tek) on dry ice. Serial sections were obtained to ensure equal sampling of the examined specimens (8μm trimming). Tissue sections were incubated for 1 hour at room temperature with anti-mouse αSMA antibody (Sigma-Aldrich; F3777). Sections were mounted with DAPI Fluoromount-G (Southern Biotech; 0100-20). Slides were visualized using Leica SP5 microscope. Quantitative analyses were performed using ImageJ Software.
Flow cytometry analysis and cell sorting
Single cell suspensions of Lungs isolated from FVB/n;Col1α1-YFP or PyMT;Col1α1-YFP mice were stained using the following antibodies: anti-EpCAM-APC (eBioscience, 17-5791), anti-CD45-PerCP-Cy5.5 (eBioscience; 45-0451), anti-CD31-PE-Cy7 (eBioscience; 25-0311). DAPI was used to exclude dead cells (Molecular Probes; D3571). Flow cytometric analysis was performed using CytoFLEX Flow Cytometer (Beckman Coulter). Cell sorting was performed using BD FACSAria II or BD FACSAria Fusion (BD bioscience). Data analysis was performed with the Kaluza Flow Analysis software (Beckman Coulter).
RNA isolation and qRT-PCR
RNA from sorted cells was isolated using the EZ-RNAII kit (20-410-100, biological industries) according to the manufacturer's protocol. RNA from in vitro experiments was isolated using the PureLink TM RNA Mini Kit (Invitrogen; 12183018A). cDNA synthesis was conducted using qScript cDNA Syntesis kit (Quanta; 95047-100). Quantitative real-time PCRs (qRT-PCR) were conducted using PerfeCTa SYBR Green Fastmix ROX (Quanta; 95073-012). In all analyses expression results were normalized to Gusb or Gapdh and to control cells. RQ (2 -ΔΔCt ) was calculated.
Transfection of primary fibroblasts
NLF were cultured in DMEM supplemented with 10% FCS. At 70% confluency, cells were transfected with Accell Delivery Media (GE Dharmacon; B-005000) supplemented with 1µM Accell SMARTpool mouse Myc siRNA (Dharmacon; E-040813) or Accell Control Pool nontargeting siRNA (Dharmacon; D-001910) for 96h. Accell SMARTpool contains a mixture of four siRNAs targeting one gene, and provide extended duration of gene knockdown with only minimal effects on cell viability and the innate immune response. The efficiency of Myc siRNA knockdown was analyzed by qRT-PCR. (Kim et al., 2013) . Gene expression counts were calculated using HTseqcount (Anders et al., 2015) using Gencode annotations. Only genes that got at least 20 counts in at least 3 replicate samples were included in subsequent analysis (12,105 genes). Gene expression counts were normalized using quantile normalization (Bolstad et al., 2003) . Levels below 20 were then set to 20 to reduce inflation of fold-change estimates for lowly expressed genes. Preliminary differential expression analysis was carried out using DESeq2 (Love et al., 2014) . For subsequent analyses, only protein coding genes were included. In addition, coefficient of variance (CV) was calculated per group (NLF, MIF, MAF) and the top 1% most in-group deviated genes (top 1% CV) were excluded, leaving a total of 11,115 genes.
RNA-seq
Stage-specific signature analysis
The top 2% most altered genes from each comparison (up/down) were selected (871 genes in total) as a primary signature for the different stages (NLF, MIF, MAF). Data was Z-scored per gene. Venn diagram was generated using Bioinformatics & Evolutionary Genomics website (http://bioinformatics.psb.ugent.be/webtools/Venn/). All hierarchical clustering (based on Euclidian distance and average linkage) and principal component analyses were performed using JMP 14 software.
Gene selection based on network connectivity
All 871 selected genes were subjected to protein-protein interactions analysis using the STRING platform (Szklarczyk et al., 2017) . The minimum confidence of interaction was defined based on the upper quartile of all interactions (confidence>0.3) and connections based on text-mining were excluded. Groups of under 4 genes were excluded, leaving a total of 491 genes ("stage-specific gene signature").
Pathway enrichment
For functional annotation, pathway and enrichment analysis, each comparison was analyzed separately, to a total of 6 comparisons (MIF vs. NLF up, MIF vs. NLF down, MAF vs. NLF up, MAF vs. NLF down, MAF vs. MIF up, MAF vs. MIF down) . Over-representation analysis was performed using the ConsensusPath DataBase CPDB, (Kamburov et al., 2011) (http://cpdb.molgen.mpg.de/MCPDB) platform for GO-molecular function (MF) and GObiological process (BP), Reactome, and KEGG. Terms larger than 500 genes were excluded. Results were considered significant with a p-value<0.01, q-value<0.05 and the top 75% highest coverage (>3%). The CPDB platform utilizes multiple databases, enables visualization of relationships between different enrichments, and allows comparison and integration between them (Herwig et al., 2016) . To increase the specificity of the enriched terms, we compared the relative overlap and the number of shared entities between the enriched terms from the three different databases (GO, KEGG and Reactome). Selected terms with at least 2 shared entities and a relative overlap > 0.2 were grouped and annotated based on a common enriched function. Groups containing more than 15-20 terms were divided to sub-groups based on a higher relative overlap criteria. Groups smaller than 5 terms were excluded. These steps enabled the selection of the ~10% most highly and significantly connected terms.
For the generation of bubble plot heat maps all q-values were log transformed [-Log 10 (qvalue)]. For the group annotation heat map, log-transformed q-values of all the terms included in a specific group were averaged. For terms enriched in a group of downregulated genes, the value of the average log transformed q-value was transformed to a negative value by duplicating the average log transformed value by (-1). For the generation of gene bubble graph heat maps per selected groups, the average of log-transformed q-values was calculated per gene, based on the enrichment terms that included it.
Gene Set Enrichment Analysis (GSEA)
The GSEA Java plug-in was used to probe log-transformed normalized expression data (Subramanian et al., 2005) 
Transcription Factor Ranking
Selection of transcription factors
Transcription factors (Hif1a, Hsf1, Myc, Nfkb1, Stat3) that were shown to be enriched in the pathway enrichment and/or GSEA analyses described above were selected as candidates and subjected to subsequent analyses. The Transcription Factors (TFs) were ranked as candidates for their relevance to the transcriptional rewiring of metastases-associated fibroblasts.
STRING
All five candidate TFs were subjected to protein-protein interaction analysis in combination with the "stage-specific gene signature" using the STRING platform (Szklarczyk et al., 2017) . The minimum confidence of interaction was defined based on the median confidence value of all interactions (confidence >0.2). For the ranking of each TF, the number of separate interactions for each TF was counted.
ANAT
The ANAT (Advanced Network Analysis Tool) application (Yosef et al., 2011) was used as an add-in to Cytoscape (version 7 and up) software. We performed the analysis for each TF separately and for all of the TFs combined. The TFs were defined as anchors in the list, and the target genes were the stage-specific list of genes. An HTML report of all possible pathways between the anchor and each gene in the target genes list was generated. The minimum confidence for a connection was defined based on the median confidence value of all interactions (confidence >0.2). An anchor could be connected to a target directly, or indirectly. For the ranking of each TF, we calculated several parameters of the proteinprotein network: 1) The number of stage-specific genes connected with each TF (directly and 2-4 shells); 2) The average shortest path for each TF;
3) The centrality of the network. Parameters 2 and 3 were calculated using the network analysis tool of the Cytoscape software.
RegNetwork
Each TF was defined as a regulator in the RegNetwork database (Liu et al., 2015) and all non-microRNA results were downloaded. For the ranking of each TF, the number of genes out of the stage-specific gene signature that are registered as targets were counted.
VarElect
Using the VarElect platform (Stelzer et al., 2016) , we analyzed the relation of the stagespecific genes with each TF. Each gene from the list received a score according to its relation to the TF. For the ranking of each TF, we analyzed several parameters: 1) the number of directly related genes; 2) The average score of related genes; 3) The average score of indirectly related genes.
Ranking
To assess the relative relevance of the candidate TFs, ranking analysis was performed. Ranking parameters described above were Z-scored per parameter. For "Characteristic path length" results were first transformed with a (-1) power. Statistical analysis was performed using One-Way ANOVA with Tukey correction for multiple comparisons.
Human breast cancer data
Stromal and epithelial expression profiles and correlation analyses
The expression of upMAG (upregulated metastases-associated genes) and Myc, Nfkb1 and Stat3 were analyzed in human breast cancer stroma and epithelial tissues based on a publicly available dataset GSE14548 (Ma et al., 2009) . Correlation analysis was performed on normalized expression values using Pearson correlation. P-value below 0.05 was considered significant.
Kaplan-Meier analyses
Overall survival analysis was performed using patient gene expression profiles generated by the Molecular Taxonomy of Breast Cancer International Consortium (METABRIC) study (Curtis et al., 2012) . Kaplan-Meier analysis was performed using MATLAB on patients stratified by gene expression (high=top 20% expression, low=bottom 80% expression). For the combination with Myc patients were divided into 4 groups: Myc high (top 20%) and upMAG gene high (top 20%), Myc high and upMAG gene low (bottom 80%), Myc low and upMAG gene high, and Myc low and upMAG gene low. p-value below 0.05 was considered significant.
Statistical analysis
Statistical analyses were performed using GraphPad Prism software and JMP pro 14 software. For two groups, statistical significance was calculated using t-test with Welch correction unless otherwise stated. For more than two comparisons, One-Way ANOVA with Tukey correction for multiple comparisons was applied unless otherwise stated. All tests were two-tailed. P-value of ≤0.05 was considered statistically significant unless otherwise stated. Bar graphs represent mean and standard deviation (SD) unless otherwise stated. All experiments represent at least 3 separate biological repeats.
Data Access
All raw and processed sequencing data generated in this study have been submitted to the NCBI Gene Expression Omnibus (GEO; http://www.ncbi.nlm.nih.gov/geo/) under accession number GSE128999.
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